What is Myocardial Solutions?
Myocardial Solutions is at the forefront of enhancing patient cardiovascular health, leveraging its proprietary MyoStrain software. This advanced technology facilitates rapid and precise assessment of cardiac function, empowering physicians to identify and manage early cardiac dysfunction in asymptomatic and at-risk individuals. By standardizing preventative heart care, the company aims to improve clinical efficiencies and reduce overall healthcare expenditures, targeting healthcare providers and institutions within the cardiology sector.
How much funding has Myocardial Solutions raised?
Myocardial Solutions has raised a total of $9.2M across 4 funding rounds:
Series B
$4M
Debt
$1M
Series A
$4M
Debt
$150K
Series B (2009): $4M with participation from Technology Development Fund
Debt (2016): $1M, investors not publicly disclosed
Series A (2016): $4M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Key Investors in Myocardial Solutions
Technology Development Fund
The Technology Development Fund is a competitive funding program designed to increase the commercialization potential of life science technologies developed by the region's scientists and entrepreneurs. The intent is to provide financial support to verify the technical and commercial feasibility of early stage inventions that will accelerate and increase the likelihood that the technology will be successfully commercialized through a regional start-up company. These funds can be used in conjunction with or to leverage other early sources of funding.
What's next for Myocardial Solutions?
The recent major strategic investment signals a pivotal growth phase for Myocardial Solutions. This capital infusion is expected to accelerate the development and market penetration of their MyoStrain software, potentially expanding its reach to a broader range of healthcare systems and patient populations. The company is poised to further solidify its position in the preventative cardiology market, driving innovation in cardiac assessment and patient outcome optimization.
See full Myocardial Solutions company page
